Search This Blog

Wednesday, April 3, 2019

Recro Pharma ups FY19 revenue view to $85-$87M from $80M, consensus $85.12M

Raises FY19 adjusted EBITDA view to $38M-$40M from $34M
https://thefly.com/landingPageNews.php?id=2888273
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)